Fragment-based screening (FBS) has become an established approach for hit identification. Starting points identified by FBS, are small fragments that require substantial modification to become leads. As fragments are different from classical hits a process tailored for fragment evolution is required. Scores for ligand efficiency have been proposed as guides for this process. Here we review how these have been applied to guide the selection and optimization of fragment hits
Fragment-based lead discovery is becoming an increasingly popular strategy for drug discovery. Fragm...
Funder: ExscientiaFunder: Diamond Light SourceFunder: Kungliga Tekniska HoegskolanFunder: Chinese Ce...
Optimisation of the affinity of lead compounds is a critical challenge in the identification of drug...
Fragment-based screening (FBS) has become an established approach for hit identification. Starting p...
Fragment-based screening (FBS) has become an established approach for hit identification. Starting p...
Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literatu...
Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literatu...
Fragment-based drug discovery (FBDD) is an innovative approach, progressively more applied in the ac...
Fragment-based drug design is an established strategy of finding new drugs. Instead of doing mass sc...
Screening against biochemical targets with compact chemical fragments has developed a reputation as ...
The first step in hit optimisation is the identification of the pharmacophore, which is normally ach...
The central idea in Fragment Based Ligand Discovery (FBLD) is to identify small, low molecular weigh...
Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical pro...
Open access. Crystallographic fragment screens provide an efficient and effective way to identify sm...
Fragment-based lead discovery (FBLD) is a powerful application for developing ligands as modulators ...
Fragment-based lead discovery is becoming an increasingly popular strategy for drug discovery. Fragm...
Funder: ExscientiaFunder: Diamond Light SourceFunder: Kungliga Tekniska HoegskolanFunder: Chinese Ce...
Optimisation of the affinity of lead compounds is a critical challenge in the identification of drug...
Fragment-based screening (FBS) has become an established approach for hit identification. Starting p...
Fragment-based screening (FBS) has become an established approach for hit identification. Starting p...
Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literatu...
Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literatu...
Fragment-based drug discovery (FBDD) is an innovative approach, progressively more applied in the ac...
Fragment-based drug design is an established strategy of finding new drugs. Instead of doing mass sc...
Screening against biochemical targets with compact chemical fragments has developed a reputation as ...
The first step in hit optimisation is the identification of the pharmacophore, which is normally ach...
The central idea in Fragment Based Ligand Discovery (FBLD) is to identify small, low molecular weigh...
Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical pro...
Open access. Crystallographic fragment screens provide an efficient and effective way to identify sm...
Fragment-based lead discovery (FBLD) is a powerful application for developing ligands as modulators ...
Fragment-based lead discovery is becoming an increasingly popular strategy for drug discovery. Fragm...
Funder: ExscientiaFunder: Diamond Light SourceFunder: Kungliga Tekniska HoegskolanFunder: Chinese Ce...
Optimisation of the affinity of lead compounds is a critical challenge in the identification of drug...